Jacobson Pharma to Announce Interim Results and Dividend

Jacobson Pharma Corporation Limited (HK:2633) has released an update.

Jacobson Pharma Corporation Limited has announced a board meeting scheduled for November 21, 2024, to approve interim results and consider an interim dividend for the six months ending September 30, 2024. This meeting could impact the company’s stock, making it a focal point for investors tracking Jacobson Pharma’s financial performance.

For further insights into HK:2633 stock, check out TipRanks’ Stock Analysis page.